---
pmid: '16807408'
title: ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein
  2B).
authors:
- Parkinson N
- Ince PG
- Smith MO
- Highley R
- Skibinski G
- Andersen PM
- Morrison KE
- Pall HS
- Hardiman O
- Collinge J
- Shaw PJ
- Fisher EM
- MRC Proteomics in ALS Study
- FReJA Consortium
journal: Neurology
year: '2006'
full_text_available: false
doi: 10.1212/01.wnl.0000231510.89311.8b
---

# ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B).
**Authors:** Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, Morrison KE, Pall HS, Hardiman O, Collinge J, Shaw PJ, Fisher EM, MRC Proteomics in ALS Study, FReJA Consortium
**Journal:** Neurology (2006)
**DOI:** [10.1212/01.wnl.0000231510.89311.8b](https://doi.org/10.1212/01.wnl.0000231510.89311.8b)

## Abstract

1. Neurology. 2006 Sep 26;67(6):1074-7. doi: 10.1212/01.wnl.0000231510.89311.8b. 
Epub 2006 Jun 28.

ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 
2B).

Parkinson N(1), Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, Morrison 
KE, Pall HS, Hardiman O, Collinge J, Shaw PJ, Fisher EM; MRC Proteomics in ALS 
Study; FReJA Consortium.

Author information:
(1)MRC Prion Unit, Institute of Neurology, University College London, London, 
UK.

Mutation in the CHMP2B gene has been implicated in frontotemporal dementia. The 
authors screened CHMP2B in patients with ALS and several cohorts of control 
samples. They identified mutations (Q206H; I29V) in two patients with non-SOD1 
ALS. Neuropathology of the Q206H case showed lower motor neuron predominant 
disease with ubiquitylated inclusions in motor neurons. Antibodies to p62 
(sequestosome 1) showed novel oligodendroglial inclusions in the motor cortex.

DOI: 10.1212/01.wnl.0000231510.89311.8b
PMID: 16807408 [Indexed for MEDLINE]
